For adjusted EPS, we expect to be in the range of $3.95 to $4.15.
Adjusted earnings per diluted share in Q4 was $1.12, compared to $0.89 in Q4 2020.
For net sales, we estimate $5.8 billion to $6 billion, an increase of 5% to 8%.
Adjusted earnings per diluted share in Q4 was $1.12, compared to $0.89 in Q4 2020.
Net sales were up 14% to $1.5 billion and adjusted EBITDA was up 18% to $330 million.
In Q4, net sales were up 14% to $1.5 billion.
Net sales were up 14% to $1.5 billion and adjusted EBITDA was up 18% to $330 million. Our organic growth forecast is 7% to 11%, of which at the midpoint assumes approximately 3% in volume and approximately 6% in price.
